Imaging Characteristics of a Follow-up 18F-AV-1451 Scan

PHASE2TerminatedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Alzheimer's Disease
Interventions
DRUG

Flortaucipir F18

370 megabecquerel (MBq) IV single-dose

DRUG

Florbetapir F 18

370 megabecquerel (MBq) IV single-dose

PROCEDURE

Brain PET Scan

positron emission tomography (PET) scan of the brain

Trial Locations (4)

63110

Center for Clinical Imaging Research, Washington University School of Medicine, St Louis

92663

Hoag Memorial Hospital, Newport Beach

92868

UC Irvine Medical Center, Orange

02114

Massachusetts General Hospital, Boston

Sponsors
All Listed Sponsors
lead

Avid Radiopharmaceuticals

INDUSTRY